Instil Bio TIL Cash Flow Statement (2020-2026)

NASDAQ TIL
$5.78 -0.16 (-2.61%)
As of: Oct 21, 2026 · 3:59 PM EDT
Reported Financials

Instil Bio Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Instil Bio reported cash from operations of -$4.64M and free cash flow of -$4.64M for the quarter ended Jun 2026, up 68.6% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-43.01M-55.35M-54.12M-58.99M-56.22M-53.84M-57.07M-18.66M-67.43M-12.93M-24.30M-14.92M-23.02M-11.90M-28.20M-21.39M-13.59M-8.19M-4.20M-4.30M
Depreciation and DepletionDep. & Depletion
0.80M0.80M0.90M1.00M1.90M2.10M1.80M1.00M1.00M1.10M1.00M1.00M0.90M0.70M0.50M0.01M0.20M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.76M0.89M0.90M1.05M1.94M2.10M1.78M0.99M0.95M1.04M0.99M0.98M0.90M0.74M0.50M0.01M0.01M0.01M0.01M0.25M
Share-based CompensationStock Comp.
8.74M8.90M7.49M8.32M7.98M6.64M4.53M4.41M4.67M4.55M4.52M4.17M4.07M4.50M3.50M1.82M1.77M1.61M0.99M1.04M
Gains from Sales and DivestituresGains Divest
-0.20M-0.04M0.24M-0.05M-0.29M0.00M-0.04M-0.29M-0.05M0.00M
Gains from Investment SecuritiesGains Investment
0.60M-0.37M0.25M-0.41M-0.62M-0.25M-0.64M0.62M-0.79M
Asset Writedowns and ImpairmentWritedown
15.83M13.10M0.92M46.07M2.53M0.25M1.51M0.04M16.57M0.03M0.18M
Cash from Restructuring
5.43M-0.21M-1.67M-0.37M-0.05M0.78M-0.85M
Other non-cash itemsOther Non-Cash
0.72M0.61M0.37M1.30M2.29M-3.11M-0.35M0.06M-3.62M0.51M10.00M-0.23M-0.01M10.00M-0.74M0.32M
Change in Working Capital
Change in Account PayablesChange Payables
1.76M0.11M-3.20M4.11M-0.23M-2.49M-0.98M0.75M-0.43M-0.48M0.02M-0.01M-0.05M-0.52M-0.38M0.24M0.40M-0.15M0.02M
Change in Accured ExpensesChange Accured Exp.
3.35M7.56M-2.93M-0.46M3.22M-14.24M-1.48M-2.56M-1.26M-2.48M0.86M-1.04M-0.17M-1.54M-1.01M-2.16M1.59M-0.77M0.05M-1.63M
Change in Other Operating AssetsOther Assets Change
1.73M5.51M3.12M2.95M-1.82M-4.17M0.71M1.81M-1.71M-2.11M-1.14M-0.46M7.26M-1.07M-6.56M0.48M0.80M-1.26M-1.61M0.08M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.46M0.36M-0.13M1.52M-0.45M-0.09M-0.67M-0.21M-0.20M-0.43M-0.36M-0.31M-0.16M-1.35M-0.05M0.09M-0.08M-0.08M
Other Working Capital ChangesOther WC Changes
-1.73M-5.51M-3.57M-2.59M1.69M5.69M-1.15M-1.91M1.04M1.90M0.94M0.03M-7.62M0.77M6.40M-1.83M-0.85M1.35M1.53M-0.17M
Cash from OperationsCash from Ops.
-29.40M-42.79M-55.05M-47.26M-40.88M-36.98M-34.66M-19.56M-14.43M-13.38M-14.39M-10.61M-20.13M-10.56M-4.20M-14.79M-10.56M-7.08M-1.34M-4.64M
Investing Activities
Capital ExpendituresCapex
21.75M18.46M20.24M26.14M25.20M13.01M8.47M6.98M5.16M0.06M
Sales of Property, Plant and EquipmentPP&E (Sale)
1.56M0.54M0.01M0.32M0.41M0.01M0.01M0.01M
Change in Property, Plant and EquipmentChange in PP&E
-21.75M-18.46M-20.24M-26.14M-25.20M-13.01M-8.47M-6.98M-5.16M1.50M0.54M0.01M0.32M0.41M0.01M0.01M0.01M
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
699.99M407.58M252.40M219.68M84.43M108.54M82.01M96.49M72.02M50.95M50.66M40.42M15.60M27.33M38.19M38.71M6.56M17.39M22.32M17.51M
Sale and Maturity of InvestmentsInvestments Sold
205.00M486.00M350.50M225.50M135.00M154.35M105.00M113.80M79.50M63.40M59.90M51.80M47.00M39.40M47.40M38.30M25.00M25.20M22.00M22.80M
Other Investing ActivitiesOther investing
0.61M
Cash from Investing ActivitiesCash from Investing
-516.73M59.96M77.87M-21.50M25.37M32.80M14.53M10.33M2.32M13.95M9.24M11.92M19.81M13.00M9.61M-0.40M8.45M7.82M-0.32M5.29M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
50.06M14.45M5.83M4.47M4.20M85.60M
Long-Term Debt RepaymentsLT Debt Repayment
82.84M
Non-Current Debt
50.06M14.45M5.83M4.47M4.20M2.76M
Net Debt Issuances and RepaymentsNet Debt Issuance
50.06M14.45M5.83M4.47M4.20M2.76M
Change in Capital Stock
Common Stock IssuedStock Issued
0.12M0.20M0.34M0.57M0.27M0.38M0.16M0.21M0.40M6.68M0.38M
Net Shares Issued and RepurchasedNet Shares Issued
0.12M0.20M0.34M0.57M0.27M0.38M0.16M0.21M0.40M6.68M0.38M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.12M0.20M0.34M0.57M0.27M0.38M0.16M0.21M0.40M6.68M0.38M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
0.12M0.20M0.34M50.62M14.72M6.20M4.47M4.20M-0.59M0.16M1.60M0.23M6.68M0.38M
Additional items
Exchange Rate EffectFX Effect
0.13M-0.18M0.73M-0.87M-0.56M0.07M-0.02M-0.07M-0.09M-0.02M-0.06M-0.01M0.04M-0.07M0.04M0.02M-0.03M-0.02M-0.01M0.00M
Change in Cash
-546.01M17.37M23.15M-18.14M-0.78M2.03M-15.67M-5.03M-12.69M0.57M-5.15M1.31M-0.16M4.04M5.65M-8.51M-1.73M0.74M-1.65M0.65M
Ending Cash Balance
20.90M38.09M61.97M42.96M41.62M43.72M28.03M22.93M10.15M10.70M5.48M6.78M6.66M10.64M16.33M7.84M6.08M6.80M5.15M5.80M
Free Cash FlowFCF
-51.14M-61.25M-75.29M-73.40M-66.08M-49.99M-43.13M-26.54M-19.58M-13.44M-14.39M-10.61M-20.13M-10.56M-4.20M-14.79M-10.56M-7.08M-1.34M-4.64M
Net Cash FlowNCF
-546.01M17.37M23.15M-18.14M-0.78M2.03M-15.67M-5.03M-12.69M0.57M-5.15M1.31M-0.16M4.04M5.65M-8.51M-1.73M0.74M-1.65M0.65M
Interest Paid
0.55M0.51M1.48M1.68M1.75M1.73M1.73M1.75M1.76M2.76M0.89M1.39M1.39M1.37M1.36M1.39M

Instil Bio Cash Flow Statement API

Pull Instil Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TIL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY